Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma

Fig. 3

Binding properties of the 32A9 IgG antibody. ELISA to detect 32A9 binding activity (a) and affinity (b) to GPC3-hFc protein. Flow cytometry to detect the 32A9 binding signal (c) and affinity (d) to GPC3-positive cells. e ELISA to detect 32A9 binding specificity to human GPC3 and mouse GPC3. f ELISA to detect 32A9 binding specificity to GPC3 and GPC5. Values represent the mean ± SD, with ***p < 0.001

Back to article page